2 blood pressure meds recalled for possibly containing a cancer-causing substance

Enlarge this image

Examples of some of the two blood pressure medications that Lupin is recalling. It’s recalling various dosages of irbesartan tablets and irbesartan and hydrochlorothiazide tablets.

FDA

hide caption

toggle caption

FDA

Health
Taking aspirin to prevent heart attack may cause more harm than good, task force says

The company found that certain batches of those drugs were «above the specification limit for the impurity N-nitrosoirbesartan,» which could cause cancer in humans. It says it’s received no reports of illness that appear to be related to this issue, but is acting out of an abundance of caution. It’s recalling:

All batches of irbesartan tablets USP 75mg, 150mg and 300mg

All batches of irbesartan and hydrochlorothiazide tablets USP, 150mg/12.5mg and 300mg/12.5mg

Lupin says it received four reports of illness from irbesartan and none from irbesartan and hydrochlorothiazide between October 2018 (when the first of these affected batches were shipped from the manufacturing site) and the end of September 2021.It discontinued the marketing of both drugs in January of this year.

Shots — Health News
Eating too much salt is making Americans sick. Even a 12% reduction can save lives

Here’s what to do

Lupin advises patients prescribed the drugs to continue taking their medication and contact their pharmacist, physician or medical provider for advice «regarding an alternative treatment.»

The company says it’s notifying wholesalers, distributors, drug chains, mail order pharmacies and supermarkets and arranging for the return of all the recalled product lots.

Images of the product packaging can be found here.